Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 2017

View Archived Issues

Lysogene's candidate for GM1 gangliosidosis wins FDA rare pediatric disease designation

Telix signs product collaboration and purchase option agreement with Atlab

FDA accepts Ezra's NDA for EZR-104 to treat hypertension and heart failure

Full phase I data reported for novel anti-HIV compound ABX-464

Novo Nordisk initiates first human dose trial of NNC0194-0499

FDA approves Imbruvica for marginal zone lymphoma

Symbiomix Therapeutics submits NDA for Solosec

AbCellera receives grant to discover monoclonal antibodies against Mtb

PhaseBio obtains financing to support study of PB-1046

hERG as a novel glioblastoma survival marker

Cytori to acquire Azaya Therapeutics assets

Discovery of new chemical probe for BRPF proteins for cellular and in vivo studies

EUROSTARS funding to support development of LiPlaCis

FDA approves Rhofade, Allergan's topical treatment for persistent facial erythema

The University of Texas patents novel GLS inhibitors

TP Therapeutics presents new protein kinase inhibitors

FDA acknowledges receipt of NDA for Shire's ADHD drug SHP-465

Lilly identifies novel MetAP2 and DPP IV inhibitors

Cynata and FUJIFILM sign license option agreement

Roche divulges novel DDR1 inhibitors

PharmAthene, Altimmune enter merger agreement

Jilin University and Shanghai Pharmaceuticals Holding identify new JAK inhibitors

FDA approves Trulance for chronic idiopathic constipation

UCB submits sNDA for Briviact in U.S.

EMA awards orphan designation to Abeona Therapeutics' ABO-101

Japanese priority review for regorafenib in second-line treatment of unresectable HCC

Merrimack Pharmaceuticals -- refocused for 2017

Suliqua approved in Europe for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026